Bayer Settles 500 Yasmin Lawsuits

Some women and their families are getting some sort of closure with a new settlement being made between themselves and Germany’s largest drug maker. According to reports, Bayer, will pay at least $110 million to settle about 500 lawsuits over claims that its Yasmin line of birth-control pills caused blood clots, in the first resolution [...]

Next Chapter in Yaz, Yasmin Saga- Lawyers Don’t Want Judge To Exclude Latest Conflict Of Interest Findings

And the story continues on the recent findings of the FDA Advisory Panel that recently ruled that Yaz and Yasmin are safe.  Now, lawyers representing Plaintiffs that are suing  Bayer over injuries from the contraceptives, are urging U.S. District Judge David Herndon to examine evidence of conflicts of interest at the U.S. Food and Drug [...]

Conflict Of Interest Concern Has One Watchdog Group Asking For Latest Yaz Review To Be Thrown Out

Last week we reported that there was something fishy going on with the safety panel that was convened in order to review the very controversial drugs, Yaz and Yasmin.  Apparently there were several reviewers that had ties to the drug maker.  The FDA, however, did not disclose the connections to the public, and the panel’s [...]

Something Fishy Going On- FDA Panelists Who Claim Benefits of Yaz Outweigh Risks Were Former Employees Of Bayer

There’s something fishy going on!  In a recent vote, an FDA advisory panel said the benefits of four popular Bayer AG birth-control pills outweigh the blood-clot risk. What the FDA didn’t tell us was that three of the advisers have had ties to Bayer, the maker of the drugs!! In December, the advisory panel for [...]

Birth control like Yaz, Yasmin may increase clot risk

Probably every woman has heard the risk for developing blood clots if she takes birth control pills, or other forms of contraceptives. But how much of a risk is now under investigation. Kristen Hallam wrote an article on April 21, 2011 that states “Birth-control pills with Drospirenone raise clot risk in study.” This study found [...]